President
Mr. Tetsuji Yamada
“We combine expertise, technology, safety, and patient care.”
Mr. Tetsuji Yamada
President at J-VPD Diagnostics India Pvt Ltd (Wholly Owned
Subsidiary of J-VPD Inc, Japan)
Mr. Tetsuji Yamada is a distinguished healthcare leader known for his commitment to advancing the field of medical diagnostics and healthcare services worldwide. With a professional background spanning over three decades, he has made significant contributions to the healthcare industry, leveraging his expertise in clinical diagnostics, medical management, and healthcare administration.
- J-VPD plays a significant role in clinical testing services, focusing on prevention, diagnosis, and treatment for various diseases.
- The company’s philosophy is to contribute to the development of a high-quality medical system, reduce social and economic burdens, and create a healthy and prosperous society.
- J-VPD is dedicated to providing accurate test results to people worldwide, addressing health and disease issues efficiently.
- Beyond clinical testing, J-VPD is involved in dialysis, distribution of advanced medical equipment and pharmaceuticals, alternative medicine products, technology transfer, establishment of hospitals, and medical marketing to support global healthcare.
- DCO, Inc. (Established in January 2005)
- J-VPD, INC. (Established in May 2016)
- J-VPD Tokyo Laboratory (Established in January 2017)
- Subsidiary in India: J-VPD Diagnostics India Pvt. Ltd. (Established in March 2017)
Corporate Office Address (Group): BELX Shinjuku Bldg. 6F, 23-14, Aizumi-cho, Shinjuku-ku, Tokyo 160-0005, Japan
Subsidiary Office Address in India: DTJ 924, DLF Tower B, Jasola, New Delhi-110025
- In 1992 got associated with a major clinical diagnostics company called SRL, Inc. Japan, engaged in sales and marketing from clinics to university hospitals, and become one of the integral contributors to make SRL Inc., the biggest laboratory in Japan and 3rd largest in the world.
Mr. Tetsuji Yamada’s leadership and J-VPD’s activities reflect a commitment to advancing healthcare and reducing the global burden of diseases through precision diagnostics and various medical services.
